United Therapeutics Corporation (UTHR)
USD 293.65
(-4.46%)
USD 293.65
(-4.46%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -507.7 Million USD | -214.95% |
| 2022 | -161.2 Million USD | -70.04% |
| 2021 | -94.8 Million USD | -254.65% |
| 2020 | 61.3 Million USD | -45.07% |
| 2019 | 111.6 Million USD | 126.62% |
| 2018 | -419.2 Million USD | 7.89% |
| 2017 | -455.1 Million USD | 55.51% |
| 2016 | -1.02 Billion USD | -23.79% |
| 2015 | -826.41 Million USD | -204.71% |
| 2014 | -271.21 Million USD | -3818.85% |
| 2013 | 7.29 Million USD | -93.97% |
| 2012 | 120.98 Million USD | 284.01% |
| 2011 | 31.5 Million USD | -40.26% |
| 2010 | 52.73 Million USD | -64.9% |
| 2009 | 150.24 Million USD | 0.31% |
| 2008 | 149.78 Million USD | 35.32% |
| 2007 | 110.69 Million USD | -30.36% |
| 2006 | 158.95 Million USD | 329.85% |
| 2005 | -69.15 Million USD | 16.23% |
| 2004 | -82.56 Million USD | -21.83% |
| 2003 | -67.76 Million USD | 43.89% |
| 2002 | -120.77 Million USD | -438.35% |
| 2001 | -22.43 Million USD | 88.73% |
| 2000 | -199.02 Million USD | -1113.59% |
| 1999 | -16.4 Million USD | -152.31% |
| 1998 | -6.5 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -651.5 Million USD | -28.32% |
| 2024 Q3 | -1.15 Billion USD | -34.85% |
| 2024 Q2 | -855.7 Million USD | -31.34% |
| 2023 Q2 | -267.3 Million USD | 26.46% |
| 2023 Q1 | -363.5 Million USD | -125.5% |
| 2023 FY | -507.7 Million USD | -214.95% |
| 2023 Q4 | -507.7 Million USD | 16.46% |
| 2023 Q3 | -607.7 Million USD | -127.35% |
| 2022 Q3 | -166.8 Million USD | -3575.0% |
| 2022 Q4 | -161.2 Million USD | 3.36% |
| 2022 FY | -161.2 Million USD | -70.04% |
| 2022 Q1 | -13.3 Million USD | 85.97% |
| 2022 Q2 | 4.8 Million USD | 136.09% |
| 2021 Q4 | -94.8 Million USD | 12.63% |
| 2021 FY | -94.8 Million USD | -254.65% |
| 2021 Q1 | -32.3 Million USD | -152.69% |
| 2021 Q2 | -142.2 Million USD | -340.25% |
| 2021 Q3 | -108.5 Million USD | 23.7% |
| 2020 Q4 | 61.3 Million USD | -52.77% |
| 2020 Q3 | 129.8 Million USD | 13.26% |
| 2020 Q1 | -75.2 Million USD | -167.38% |
| 2020 Q2 | 114.6 Million USD | 252.39% |
| 2020 FY | 61.3 Million USD | -45.07% |
| 2019 Q3 | 280.3 Million USD | 66.15% |
| 2019 Q4 | 111.6 Million USD | -60.19% |
| 2019 FY | 111.6 Million USD | 126.62% |
| 2019 Q1 | 259.4 Million USD | 161.88% |
| 2019 Q2 | 168.7 Million USD | -34.97% |
| 2018 Q2 | -495.9 Million USD | 27.36% |
| 2018 Q1 | -682.7 Million USD | -50.01% |
| 2018 FY | -419.2 Million USD | 7.89% |
| 2018 Q4 | -419.2 Million USD | -3.25% |
| 2018 Q3 | -406 Million USD | 18.13% |
| 2017 Q2 | -755.9 Million USD | 32.67% |
| 2017 FY | -455.1 Million USD | 55.51% |
| 2017 Q1 | -1.12 Billion USD | -9.74% |
| 2017 Q3 | -817.5 Million USD | -8.15% |
| 2017 Q4 | -455.1 Million USD | 44.33% |
| 2016 Q1 | -841.4 Million USD | -1.81% |
| 2016 FY | -1.02 Billion USD | -23.79% |
| 2016 Q2 | -836.6 Million USD | 0.57% |
| 2016 Q3 | -953 Million USD | -13.91% |
| 2016 Q4 | -1.02 Billion USD | -7.35% |
| 2015 Q4 | -826.41 Million USD | -12.41% |
| 2015 Q2 | -222.07 Million USD | 28.66% |
| 2015 Q1 | -311.28 Million USD | -14.77% |
| 2015 FY | -826.41 Million USD | -204.71% |
| 2015 Q3 | -735.18 Million USD | -231.05% |
| 2014 Q4 | -271.21 Million USD | -31.67% |
| 2014 Q3 | -205.97 Million USD | -297.52% |
| 2014 Q2 | 104.28 Million USD | 183.6% |
| 2014 Q1 | -124.74 Million USD | -1810.42% |
| 2014 FY | -271.21 Million USD | -3818.85% |
| 2013 Q3 | -38.96 Million USD | 38.21% |
| 2013 FY | 7.29 Million USD | -93.97% |
| 2013 Q4 | 7.29 Million USD | 118.72% |
| 2013 Q2 | -63.06 Million USD | -504.96% |
| 2013 Q1 | 15.57 Million USD | -87.13% |
| 2012 FY | 120.98 Million USD | 284.01% |
| 2012 Q3 | 9.94 Million USD | -91.26% |
| 2012 Q1 | 111.49 Million USD | 253.92% |
| 2012 Q4 | 120.98 Million USD | 1116.49% |
| 2012 Q2 | 113.74 Million USD | 2.02% |
| 2011 Q1 | 20.04 Million USD | -61.99% |
| 2011 FY | 31.5 Million USD | -40.26% |
| 2011 Q4 | 31.5 Million USD | 218.8% |
| 2011 Q3 | -26.51 Million USD | -234.7% |
| 2011 Q2 | -7.92 Million USD | -139.52% |
| 2010 FY | 52.73 Million USD | -64.9% |
| 2010 Q1 | 64.73 Million USD | -56.91% |
| 2010 Q4 | 52.73 Million USD | -0.31% |
| 2010 Q3 | 52.89 Million USD | 299.2% |
| 2010 Q2 | -26.55 Million USD | -141.02% |
| 2009 Q1 | 139.91 Million USD | -6.59% |
| 2009 FY | 150.24 Million USD | 0.31% |
| 2009 Q4 | 150.24 Million USD | 34.05% |
| 2009 Q3 | 112.08 Million USD | 2.72% |
| 2009 Q2 | 109.11 Million USD | -22.01% |
| 2008 Q4 | 149.78 Million USD | 5.48% |
| 2008 FY | 149.78 Million USD | 35.32% |
| 2008 Q1 | 72.35 Million USD | -34.63% |
| 2008 Q2 | 124.64 Million USD | 72.27% |
| 2008 Q3 | 142 Million USD | 13.93% |
| 2007 Q1 | 182.17 Million USD | 14.6% |
| 2007 Q4 | 110.69 Million USD | -37.28% |
| 2007 Q2 | 168.53 Million USD | -7.48% |
| 2007 FY | 110.69 Million USD | -30.36% |
| 2007 Q3 | 176.47 Million USD | 4.71% |
| 2006 FY | 158.95 Million USD | 329.85% |
| 2006 Q4 | 158.95 Million USD | 427.78% |
| 2006 Q3 | -48.49 Million USD | 31.99% |
| 2006 Q2 | -71.3 Million USD | 18.6% |
| 2006 Q1 | -87.6 Million USD | -26.67% |
| 2005 Q1 | -82.79 Million USD | -0.28% |
| 2005 Q2 | -55.72 Million USD | 32.69% |
| 2005 Q3 | -70.42 Million USD | -26.38% |
| 2005 Q4 | -69.15 Million USD | 1.8% |
| 2005 FY | -69.15 Million USD | 16.23% |
| 2004 Q1 | -68.47 Million USD | -1.06% |
| 2004 FY | -82.56 Million USD | -21.83% |
| 2004 Q4 | -82.56 Million USD | 4.39% |
| 2004 Q3 | -86.34 Million USD | -15.99% |
| 2004 Q2 | -74.44 Million USD | -8.71% |
| 2003 Q2 | -88.23 Million USD | 0.18% |
| 2003 FY | -67.76 Million USD | 43.89% |
| 2003 Q3 | -83.93 Million USD | 4.87% |
| 2003 Q4 | -67.76 Million USD | 19.27% |
| 2003 Q1 | -88.39 Million USD | 26.81% |
| 2002 Q2 | -13.64 Million USD | 27.48% |
| 2002 Q1 | -18.8 Million USD | 16.16% |
| 2002 Q3 | -131.91 Million USD | -867.12% |
| 2002 Q4 | -120.77 Million USD | 8.44% |
| 2002 FY | -120.77 Million USD | -438.35% |
| 2001 Q4 | -22.43 Million USD | 73.46% |
| 2001 Q3 | -84.51 Million USD | 47.62% |
| 2001 FY | -22.43 Million USD | 88.73% |
| 2001 Q1 | -181.48 Million USD | 8.82% |
| 2001 Q2 | -161.36 Million USD | 11.08% |
| 2000 Q1 | -100.96 Million USD | -515.66% |
| 2000 FY | -199.02 Million USD | -1113.59% |
| 2000 Q3 | -222.49 Million USD | -138.65% |
| 2000 Q4 | -199.02 Million USD | 10.55% |
| 2000 Q2 | -93.23 Million USD | 7.66% |
| 1999 Q2 | -3.8 Million USD | 74.83% |
| 1999 Q4 | -16.4 Million USD | -310.0% |
| 1999 FY | -16.4 Million USD | -152.31% |
| 1999 Q3 | -4 Million USD | -5.26% |
| 1999 Q1 | -15.1 Million USD | 0.0% |
| 1998 FY | -6.5 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -807.58% |
| Alkermes plc | -166.73 Million USD | -204.488% |
| Agenus Inc. | 274.13 Million USD | 285.2% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 127.151% |
| Aptorum Group Limited | 1.35 Million USD | 37512.144% |
| Ardelyx, Inc. | 34.51 Million USD | 1571.083% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 11962.15% |
| Bicycle Therapeutics plc | -481.46 Million USD | -5.449% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 1503.921% |
| ChromaDex Corporation | -24.04 Million USD | -2011.194% |
| Chimerix, Inc. | -25.51 Million USD | -1889.654% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 7386.086% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -2044.275% |
| CRISPR Therapeutics AG | -150.84 Million USD | -236.571% |
| Precision BioSciences, Inc. | -85.41 Million USD | -494.427% |
| Dyadic International, Inc. | -6.37 Million USD | -7860.052% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -3086.468% |
| Fortress Biotech, Inc. | 7.66 Million USD | 6723.614% |
| Lantern Pharma Inc. | -21.7 Million USD | -2239.278% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -359.303% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -5842.755% |
| Incyte Corporation | -3.17 Billion USD | 84.01% |
| IO Biotech, Inc. | -140.69 Million USD | -260.841% |
| Jaguar Health, Inc. | 29.39 Million USD | 1827.4% |
| Novavax, Inc. | -298.29 Million USD | -70.201% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 9612.835% |
| Opthea Limited | 28.15 Million USD | 1903.076% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -2924.004% |
| ContextLogic Inc. | -232 Million USD | -118.836% |
| MiMedx Group, Inc. | -33.9 Million USD | -1397.596% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 5079.892% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -21811.7% |
| NextCure, Inc. | -6.47 Million USD | -7738.505% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -905.327% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -7858.928% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 4274.043% |
| Vaxcyte, Inc. | -368.22 Million USD | -37.877% |
| PDS Biotechnology Corporation | -32.7 Million USD | -1452.177% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 3038.419% |
| Pharming Group N.V. | 109.8 Million USD | 562.369% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -2818.487% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -189.733% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -2641.382% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -2641.382% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -7050.704% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -8563.823% |
| Acelyrin, Inc. | -216.9 Million USD | -134.068% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -8949.48% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -29348.956% |
| Summit Therapeutics Inc. | 34.67 Million USD | 1564.209% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -7362.884% |
| Senti Biosciences, Inc. | 1.74 Million USD | 29278.161% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -175.017% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -555.511% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -8275.124% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 508975.502% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 80943.949% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -333.761% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -201.784% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 557.924% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -6583.781% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -293.218% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 7463.736% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -109.479% |
| Immix Biopharma, Inc. | -17.5 Million USD | -2799.521% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -60.308% |
| MEI Pharma, Inc. | -3.7 Million USD | -13603.104% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 4158.029% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 413.895% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1926.719% |
| Fortress Biotech, Inc. | 7.66 Million USD | 6723.614% |
| Precigen, Inc. | -481 Thousand USD | -105450.936% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 3705.568% |
| AlloVir, Inc. | -62.69 Million USD | -709.832% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -812.9% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 923.306% |
| ImmuCell Corporation | 10.99 Million USD | 4719.418% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -229.363% |
| Onconetix, Inc. | 5.33 Million USD | 9622.761% |
| PureTech Health plc | -167.19 Million USD | -203.654% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -1566.776% |
| Elevation Oncology, Inc. | -19.11 Million USD | -2555.613% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -10242.229% |
| Seer, Inc. | -4.24 Million USD | -11874.057% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -2012.16% |
| Innoviva, Inc. | 255.56 Million USD | 298.659% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -808.814% |
| ESSA Pharma Inc. | -33.62 Million USD | -1410.042% |
| GlycoMimetics, Inc. | -40.98 Million USD | -1138.763% |
| GT Biopharma, Inc. | -1.02 Million USD | -49625.759% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -649.008% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 928.803% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -278.657% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -3564.117% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -1658.451% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -673832.089% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -1545.065% |
| Aptose Biosciences Inc. | -8.19 Million USD | -6095.349% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -16125.538% |
| Soligenix, Inc. | -4.95 Million USD | -10153.258% |
| Century Therapeutics, Inc. | 847 Thousand USD | 60040.968% |
| Kura Oncology, Inc. | -20.11 Million USD | -2423.611% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -1140.532% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -5945.487% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 27969.649% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -15780.513% |
| Autolus Therapeutics plc | -186.59 Million USD | -172.081% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -929.734% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -84.087% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 1581.557% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 408.88% |
| GRI Bio, Inc. | -1.79 Million USD | -28199.889% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -5551.758% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -1426.596% |
| IGM Biosciences, Inc. | -72.6 Million USD | -599.254% |
| INmune Bio, Inc. | -25.41 Million USD | -1897.954% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 436.334% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -902.191% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -3024.428% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -17498.372% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 1435.525% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -1132.73% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 1692.285% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 234.33% |
| Verastem, Inc. | -37.27 Million USD | -1261.929% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -5495.724% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -878.944% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -3254.476% |
| Histogen Inc. | -7.48 Million USD | -6681.087% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -2249.721% |
| Surrozen, Inc. | -32.66 Million USD | -1454.311% |
| Organovo Holdings, Inc. | -1.5 Million USD | -33589.449% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -11978.065% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 2777.713% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 19507.492% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 12316.073% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -5957.641% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -1068.685% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -3382.917% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -60.264% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -70212.716% |
| Apollomics, Inc. | -27.39 Million USD | -1753.258% |
| Amarin Corporation plc | -191.04 Million USD | -165.756% |
| Mesoblast Limited | 55.96 Million USD | 1007.207% |
| Turnstone Biologics Corp. | -14.58 Million USD | -3381.212% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -1907.354% |
| Synaptogenix, Inc. | -28.66 Million USD | -1671.366% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -54141.453% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 1141.821% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -58791.831% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -6887.261% |
| Exelixis, Inc. | -73.05 Million USD | -595.003% |
| Better Therapeutics, Inc. | -860 Thousand USD | -58934.884% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -2014.271% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -110.34% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 69074.793% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -6725.636% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 40586.443% |
| Gritstone bio, Inc. | 39.49 Million USD | 1385.642% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -503.679% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -19188.488% |
| Avid Bioservices, Inc. | 169.72 Million USD | 399.126% |
| Insmed Incorporated | 721.62 Million USD | 170.356% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -5453.786% |
| MediWound Ltd. | -5.32 Million USD | -9439.647% |
| OmniAb, Inc. | 9.2 Million USD | 5616.679% |
| Alector, Inc. | -35.63 Million USD | -1324.643% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 690.548% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -10202.354% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 3934.882% |
| Zai Lab Limited | -775 Million USD | 34.49% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 249.08% |
| Aura Biosciences, Inc. | -21.52 Million USD | -2258.653% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -515.543% |
| Immunic, Inc. | -45.34 Million USD | -1019.762% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -162.764% |
| Veracyte, Inc. | -203.82 Million USD | -149.087% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 179.54% |
| FibroGen, Inc. | 56.76 Million USD | 994.358% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 5801.291% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -17858.446% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -24422.447% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 111.06% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -15096.049% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -205.91% |
| TG Therapeutics, Inc. | 17.86 Million USD | 2942.347% |
| Galecto, Inc. | -21.21 Million USD | -2293.005% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -2034.539% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 132.35% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1974.616% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -4312.097% |
| XBiotech Inc. | -200.02 Million USD | -153.821% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -503.679% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 11312.456% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -1339.753% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -557.489% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 9021.103% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -197.92% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -449.614% |
| Vaxxinity, Inc. | 10.13 Million USD | 5110.857% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 168.956% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -4615.093% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -669.756% |
| NexImmune, Inc. | -3.13 Million USD | -16101.59% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -14604.549% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -3259.704% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -1773.432% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -5556.161% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -407445.655% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -1151.356% |
| Ainos, Inc. | 4.07 Million USD | 12549.95% |
| Pluri Inc. | 22.82 Million USD | 2323.926% |
| Prothena Corporation plc | -608.34 Million USD | 16.544% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -327.515% |
| Celularity Inc. | 65.19 Million USD | 878.8% |
| Rallybio Corporation | -24.1 Million USD | -2006.464% |
| Cue Biopharma, Inc. | -33.81 Million USD | -1401.227% |
| MeiraGTx Holdings plc | -40.3 Million USD | -1159.739% |
| Omeros Corporation | 331.17 Million USD | 253.302% |
| Humacyte, Inc. | -22.48 Million USD | -2157.849% |
| Immunocore Holdings plc | -358.59 Million USD | -41.581% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1965.921% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -1542.989% |
| Blueprint Medicines Corporation | 702.83 Million USD | 172.236% |
| CalciMedica, Inc. | -5.53 Million USD | -9080.832% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -169.738% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -4870.629% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -1168.077% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -1426.78% |
| Pulmatrix, Inc. | -10.41 Million USD | -4773.764% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -8394.228% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -1231.079% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -355.737% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -746.957% |
| Cytokinetics, Incorporated | 642.37 Million USD | 179.035% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -8618.873% |
| Nutriband Inc. | -251.65 Thousand USD | -201642.848% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -1388.027% |
| Vor Biopharma Inc. | 4.3 Million USD | 11906.977% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 91.589% |
| Evogene Ltd. | -19.63 Million USD | -2485.821% |
| ProKidney Corp. | -56.23 Million USD | -802.802% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -943.105% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -5396.262% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 137.224% |
| CorMedix Inc. | -43.05 Million USD | -1079.258% |
| BioLineRx Ltd. | 7.33 Million USD | 7020.665% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -1748.534% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 1200.18% |
| Atai Life Sciences N.V. | -28.55 Million USD | -1677.786% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 22861.417% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -2125.193% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 2962.701% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -576.266% |
| MediciNova, Inc. | -50.78 Million USD | -899.734% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -544.248% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -2256845.988% |
| GeoVax Labs, Inc. | -6.45 Million USD | -7768.16% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -154.077% |
| Biomea Fusion, Inc. | -166.57 Million USD | -204.797% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -183.671% |
| Mereo BioPharma Group plc | -51.46 Million USD | -886.419% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -435.3% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -72.829% |
| Absci Corporation | -72.59 Million USD | -599.331% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 11219.141% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -116.561% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -438.897% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -430.534% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -1199.363% |
| Allakos Inc. | -24.97 Million USD | -1932.833% |
| Imunon, Inc. | -4.21 Million USD | -11948.359% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -3343.902% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -274.963% |
| BioAtla, Inc. | -109.01 Million USD | -365.733% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 69074.793% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -53968.158% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 4342.855% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -2294.472% |
| XOMA Corporation | -29 Million USD | -1650.69% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -2965.821% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -5531.1% |
| aTyr Pharma, Inc. | -7.44 Million USD | -6715.68% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -307.346% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -143.894% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -520.82% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -447.309% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -58990.951% |
| Akari Therapeutics, Plc | -3.84 Million USD | -13104.161% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 31383.698% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 136.766% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -42630.834% |
| UroGen Pharma Ltd. | 4.39 Million USD | 11662.286% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 547.388% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 705611.242% |
| Orgenesis Inc. | 21.78 Million USD | 2430.61% |
| Entera Bio Ltd. | -10.62 Million USD | -4676.555% |
| GH Research PLC | -78.07 Million USD | -550.256% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -2177.907% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -1804.423% |
| Xencor, Inc. | 29.64 Million USD | 1812.657% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -25674.033% |
| Replimune Group, Inc. | 1.41 Million USD | 36056.091% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -207202.334% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -301.607% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -42630.834% |
| Portage Biotech Inc. | -4.98 Million USD | -10092.732% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -2256845.988% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -667.823% |
| OncoCyte Corporation | -6.56 Million USD | -7635.792% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 56673.729% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -11044.42% |
| Purple Biotech Ltd. | -14.13 Million USD | -3491.031% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -2037.144% |
| scPharmaceuticals Inc. | -6.54 Million USD | -7657.066% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -2941.547% |
| HilleVax, Inc. | -165.48 Million USD | -206.795% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -19903.94% |
| Tharimmune, Inc. | -10.93 Million USD | -4542.74% |
| Genprex, Inc. | -6.73 Million USD | -7435.292% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | -37.66% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -473.932% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -36138.401% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -15206.249% |
| OKYO Pharma Limited | -826.84 Thousand USD | -61301.854% |
| Savara Inc. | 153 Thousand USD | 331930.065% |
| Curis, Inc. | -23.88 Million USD | -2025.424% |
| Daré Bioscience, Inc. | -5.15 Million USD | -9743.132% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -65324.246% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -8078.157% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 42943.882% |
| BeiGene, Ltd. | -2.25 Billion USD | 77.466% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 4214.763% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 16.525% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -173.566% |
| Erasca, Inc. | -37.21 Million USD | -1264.198% |
| bluebird bio, Inc. | 108.57 Million USD | 567.62% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -39320.977% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 234.047% |
| DBV Technologies S.A. | -126.98 Million USD | -299.808% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -39320.977% |
| Moderna, Inc. | -2.9 Billion USD | 82.535% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -4804.366% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -4571.513% |
| Molecular Templates, Inc. | 707 Thousand USD | 71910.467% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -1518.374% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 246.477% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -518.679% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -453.472% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -1473.19% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -1376.902% |
| MacroGenics, Inc. | -66.98 Million USD | -657.931% |
| RenovoRx, Inc. | -1.17 Million USD | -43182.182% |
| Adicet Bio, Inc. | -138.78 Million USD | -265.812% |
| Prime Medicine, Inc. | -27.94 Million USD | -1717.043% |
| Aditxt, Inc. | 18.12 Million USD | 2901.74% |
| Adagene Inc. | -87.62 Million USD | -479.385% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -12088.423% |
| Quantum-Si incorporated | -118.55 Million USD | -328.233% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 1510.082% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -6692.711% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -946.61% |
| SciSparc Ltd. | -2.06 Million USD | -24485.956% |
| Vericel Corporation | 1.27 Million USD | 39857.244% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -4133.761% |
| Minerva Neurosciences, Inc. | 41 Million USD | 1338.164% |
| Generation Bio Co. | 31.44 Million USD | 1714.411% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -189.512% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -1541.82% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 535.446% |
| Invivyd, Inc. | -198.47 Million USD | -155.799% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -462.424% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -21074.562% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -617.192% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -7338.828% |
| 2seventy bio, Inc. | 181.71 Million USD | 379.394% |
| ADMA Biologics, Inc. | 90.06 Million USD | 663.698% |
| Clene Inc. | 3.34 Million USD | 15300.599% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -5489.746% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -2260.188% |
| GeoVax Labs, Inc. | -6.45 Million USD | -7768.16% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -47.534% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -1852.716% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 385.761% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -12308.449% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 10249.94% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -9646.592% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -289.627% |
| Evaxion Biotech A/S | 5.28 Million USD | 9703.083% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -351.016% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -286.751% |
| Trevena, Inc. | 2.25 Million USD | 22584.5% |
| Surrozen, Inc. | -32.66 Million USD | -1454.311% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -885.634% |
| Cingulate Inc. | 3.08 Million USD | 16569.42% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -17186.347% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 7164.144% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -5364.294% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -540.041% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -286.225% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -381.041% |
| Clearmind Medicine Inc. | -3.94 Million USD | -12777.168% |
| Kronos Bio, Inc. | -36.05 Million USD | -1308.166% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 5495.898% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 34918.641% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -835.749% |
| Statera Biopharma, Inc. | 14.41 Million USD | 3621.682% |
| ImmunityBio, Inc. | 618.22 Million USD | 182.122% |
| Korro Bio, Inc. | -132.94 Million USD | -281.893% |
| Kineta, Inc. | -4.54 Million USD | -11080.357% |
| BioVie Inc. | -17.73 Million USD | -2763.129% |
| Codexis, Inc. | -43.27 Million USD | -1073.303% |
| Celularity Inc. | 65.19 Million USD | 878.8% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -15920.827% |
| Celcuity Inc. | 6.78 Million USD | 7584.327% |
| Virax Biolabs Group Limited | -3.36 Million USD | -14987.918% |
| Cibus, Inc. | -8.07 Million USD | -6184.972% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -11905.202% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 11209.409% |
| IN8bio, Inc. | -16.38 Million USD | -2997.81% |
| Kodiak Sciences Inc. | -103.87 Million USD | -388.761% |
| Annexon, Inc. | -193.75 Million USD | -162.032% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 1410377.778% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -2801.309% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -14352.035% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 148.156% |
| Eyenovia, Inc. | 1.25 Million USD | 40435.202% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1987.01% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -15555.257% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -1427.055% |
| Arcellx, Inc. | -296.95 Million USD | -70.967% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -2502.789% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -762.335% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -2349.462% |
| Moolec Science SA | 117.61 Thousand USD | 431758.958% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -1222.17% |
| Geron Corporation | 14.76 Million USD | 3539.469% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -1238.942% |
| Royalty Pharma plc | 5.65 Billion USD | 108.973% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -258.999% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -7163.832% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -9366.965% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -260.759% |
| Humacyte, Inc. | -22.48 Million USD | -2157.849% |
| Structure Therapeutics Inc. | -124.33 Million USD | -308.319% |
| 89bio, Inc. | -289.05 Million USD | -75.643% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -1911.33% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -28374.481% |
| Genelux Corporation | -6.89 Million USD | -7259.038% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -1534.631% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 707.304% |
| Notable Labs, Ltd. | -9.77 Million USD | -5093.331% |
| Liquidia Corporation | -80.17 Million USD | -533.232% |
| Mustang Bio, Inc. | -3.73 Million USD | -13489.4% |
| Immunovant, Inc. | -635.22 Million USD | 20.076% |
| Quantum-Si incorporated | -118.55 Million USD | -328.233% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -2790.572% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -12154.405% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 6424.903% |
| Acasti Pharma Inc. | -23 Million USD | -2106.912% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -14977.68% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -3024.428% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -268.593% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -16191.432% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -2183.645% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -2634.127% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -199.921% |
| PepGen Inc. | -60.67 Million USD | -736.822% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -2109.697% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -2554.502% |
| Solid Biosciences Inc. | -47.75 Million USD | -963.246% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -58791.831% |
| Immuneering Corporation | -54.94 Million USD | -824.051% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -11978.065% |
| Silo Pharma, Inc. | -3.52 Million USD | -14305.665% |
| Belite Bio, Inc | -87.27 Million USD | -481.751% |
| XOMA Corporation | -29 Million USD | -1650.69% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -618.135% |
| Bionomics Limited | 227 Million USD | 323.647% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -336.611% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -19943.427% |
| uniQure N.V. | -102.95 Million USD | -393.147% |
| Cassava Sciences, Inc. | -121.13 Million USD | -319.116% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -12088.423% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 1339.774% |
| Forte Biosciences, Inc. | -11.96 Million USD | -4144.628% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -16308.118% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 479062.264% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -15555.257% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 5801.291% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -6746.009% |
| Altimmune, Inc. | -134.48 Million USD | -277.509% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 356.33% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -19943.427% |
| Compugen Ltd. | -12.9 Million USD | -3834.439% |
| Peak Bio, Inc. | 10.34 Million USD | 5009.983% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -179299.293% |
| Benitec Biopharma Inc. | -50.58 Million USD | -903.717% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -386.592% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 2684.373% |
| Zura Bio Limited | -99.8 Million USD | -408.687% |
| PolyPid Ltd. | 6.17 Million USD | 8328.525% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 784.97% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 2684.373% |
| Instil Bio, Inc. | 75.35 Million USD | 773.717% |
| argenx SE | -2.02 Billion USD | 74.976% |
| Immunome, Inc. | -97.02 Million USD | -423.246% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -2156.946% |
| Verona Pharma plc | -220.44 Million USD | -130.309% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -607.665% |
| Shattuck Labs, Inc. | -121.42 Million USD | -318.122% |
| CervoMed Inc. | -7.79 Million USD | -6414.95% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -173.694% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -11509.879% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -285.38% |
| Moolec Science SA | 117.61 Thousand USD | 431758.958% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -22089.908% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 3293.407% |
| AnaptysBio, Inc. | -18.15 Million USD | -2697.091% |
| Design Therapeutics, Inc. | -18.15 Million USD | -2697.245% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -621.359% |
| NeurAxis, Inc. | 145.7 Thousand USD | 348555.731% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 4620.121% |
| Lumos Pharma, Inc. | -28.49 Million USD | -1681.841% |
| Achilles Therapeutics plc | -126.92 Million USD | -300.003% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -607.665% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -77325.16% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -2343.941% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 34918.641% |
| Nutriband Inc. | -251.65 Thousand USD | -201642.848% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -3754.681% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -6723.925% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 249.237% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 2239.035% |
| MoonLake Immunotherapeutics | -447.47 Million USD | -13.46% |
| Palisade Bio, Inc. | -12.06 Million USD | -4108.737% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -261.839% |
| Beam Therapeutics Inc. | -262.72 Million USD | -93.246% |
| Neurogene Inc. | -131.95 Million USD | -284.752% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 2427.191% |
| AEON Biopharma, Inc. | -4.88 Million USD | -10303.689% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | -34.6% |
| Sesen Bio, Inc. | -112.55 Million USD | -351.076% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -408.412% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -21524.564% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -1200.928% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -509.616% |
| Athira Pharma, Inc. | -88.99 Million USD | -470.456% |
| Vaccinex, Inc. | -1.28 Million USD | -39317.702% |
| HCW Biologics Inc. | 2.85 Million USD | 17872.404% |
| XOMA Corporation | -29 Million USD | -1650.69% |
| Nektar Therapeutics | 210.24 Million USD | 341.486% |
| Arvinas, Inc. | -313.8 Million USD | -61.791% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 31383.698% |
| Merus N.V. | -192.88 Million USD | -163.215% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 946.378% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -7217.671% |
| Rezolute, Inc. | -68.16 Million USD | -644.778% |
| Clene Inc. | 3.34 Million USD | 15300.599% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -3750.004% |
| BeyondSpring Inc. | -13.75 Million USD | -3591.021% |
| Synlogic, Inc. | -6.68 Million USD | -7494.615% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 44870.723% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -5904.731% |
| Peak Bio, Inc. | 10.34 Million USD | 5009.983% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -515.991% |
| Krystal Biotech, Inc. | -350.23 Million USD | -44.96% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 509.023% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -200.421% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -15980.99% |
| MannKind Corporation | 143.89 Million USD | 452.817% |
| Ikena Oncology, Inc. | -109.15 Million USD | -365.114% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -6605.851% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -1433.837% |
| Gossamer Bio, Inc. | 180.35 Million USD | 381.5% |
| CohBar, Inc. | -5.93 Million USD | -8460.496% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -1606.669% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 11219.141% |
| Legend Biotech Corporation | -949.39 Million USD | 46.524% |
| Mural Oncology plc | -255.84 Million USD | -98.442% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 1675.974% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -10677.724% |
| Disc Medicine, Inc. | -358.28 Million USD | -41.704% |
| Champions Oncology, Inc. | 4.81 Million USD | 10650.707% |
| REGENXBIO Inc. | 54.76 Million USD | 1027.001% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -188701.333% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -236.172% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -5533.596% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -529.253% |
| Vaxart, Inc. | -8.24 Million USD | -6060.66% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -911.758% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -299.243% |
| Cellectis S.A. | -43.85 Million USD | -1057.679% |
| Longeveron Inc. | -2.9 Million USD | -17358.735% |
| Repare Therapeutics Inc. | -107.85 Million USD | -370.711% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 152.428% |
| Inozyme Pharma, Inc. | 12 Million USD | 4329.424% |
| Revolution Medicines, Inc. | -608.2 Million USD | 16.525% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -41176.423% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -91.5% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -238.304% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -3144.711% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -68508.108% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 94.691% |
| Denali Therapeutics Inc. | -74.86 Million USD | -578.154% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -4133.761% |
| Veru Inc. | 4.77 Million USD | 10721.408% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -4414.494% |
| Cingulate Inc. | 3.08 Million USD | 16569.42% |
| Passage Bio, Inc. | 4.58 Million USD | 11173.064% |
| Context Therapeutics Inc. | -14.44 Million USD | -3413.537% |
| Exicure, Inc. | 5.84 Million USD | 8780.116% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -120.379% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -1183.043% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 3335.613% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -763.127% |
| Nuvalent, Inc. | -335.38 Million USD | -51.377% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 29373.367% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -581.641% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -5610.911% |
| OmniAb, Inc. | 9.2 Million USD | 5616.679% |
| Anew Medical, Inc. | 1.43 Million USD | 35542.402% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 3199.18% |
| Lipocine Inc. | -4.75 Million USD | -10578.098% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -362.268% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 3433.333% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -902.191% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 2139.611% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -7453.935% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -671.264% |
| Ocugen, Inc. | -32.52 Million USD | -1461.145% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -493.281% |
| Q32 Bio Inc. | -37.94 Million USD | -1237.883% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -80743.949% |
| Alumis Inc. Common Stock | -13.52 Million USD | -3652.679% |
| Equillium, Inc. | -22.39 Million USD | -2167.328% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -1885.685% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -1456.084% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -204687.931% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 478.762% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 15975.547% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 154678.752% |
| Dominari Holdings Inc. | 195 Thousand USD | 260458.974% |
| Edesa Biotech, Inc. | -5.26 Million USD | -9539.428% |
| vTv Therapeutics Inc. | -8.91 Million USD | -5593.619% |
| Bio-Techne Corporation | 267.74 Million USD | 289.619% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -3032.211% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -329.912% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -5941.89% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -3913.121% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -107.124% |
| Nkarta, Inc. | 57.29 Million USD | 986.054% |
| BioCardia, Inc. | 212 Thousand USD | 239581.132% |
| Iterum Therapeutics plc | 13.43 Million USD | 3878.092% |